Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

We are very pleased to announce that Sheraz Markar has been awarded the title of Associate Professor by the University of Oxford.

Associate Professor Sheraz Markar is an academic Oesophago-Gastric Surgeon and Co-deputy Director of the Surgical Interventional Trials Unit, Nuffield Department of Surgical Sciences (SITU NDS).

Associate Professor Sheraz MarkarAssociate Professor Markar qualified in Medicine from Cambridge University in 2007. He undertook his academic and surgical training in Cambridge, London and Oxford, including NIHR Doctoral Research and Clinical Trials Fellowship and NIHR Academic Clinical Lectureship. He has completed two PhD degrees, at Imperial College London developing a breath test for oesophago-gastric cancer and at Karolinska Institutet, Sweden, concerning complex statistical modelling of surgical outcomes from oesophagectomy. He has a strong academic and clinical interest in the management of benign and malignant upper gastrointestinal disease, with over 270 publications. He is a member and chair of several surgical committees including European Association of Endoscopic Surgery and European Society for Diseases of the Esophagus, and has received several research awards including the Royal College of Surgeons Hunterian Professorship 2020 and United European Gastroenterology Rising Star 2019. 

The focus of Associate Professor Markar’s research in Oxford is the design and implementation of challenging trials to improve the clinical outcomes for patients with oesophageal and gastric disease. He has recently received funding from the NIHR-HTA to undertake the largest international RCT concerning surveillance after oesophageal and gastric resection (SARONG trial), which will bring together a diverse team of researchers and clinicians to address this key clinical question. 

Similar stories

JNDS: new issue published

A new issue of Journal of the Nuffield Department of Surgical Sciences (JNDS) has just been published.

NDS SITU host first ever Surgical Trials Showcase

The first ever showcase of the Surgical Intervention Trials Unit, Nuffield Department of Surgical Sciences (NDS SITU) was hosted on Monday 23 January 2023 at the Richard Doll Building on Old Road Campus, Oxford, and also online.

Mr Gurdeep S. Mannu awarded Cancer Research UK Clinician Scientist Fellowship

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

Blog posts

Marathon challenge for Prostate Cancer UK

Runners of all abilities started 2023 by challenging themselves to run 26.2 miles across January to fundraise for Prostate Cancer UK as part of the charity’s Run the Month: Marathon Edition.

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.